Clinical and economic choices in the treatment of respiratory infections in cystic fibrosis: Comparing hospital and home care

Journal of Cystic Fibrosis

Volumn 4, Issue 4, 2005, Pages 239-247

  Thornton, Judith ^a   Elliott, R A ^a   Tully, M P ^a   Dodd, M ^b   Webb, A K ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

Cost effectiveness; Cystic fibrosis; Home therapy; Respiratory infection

Indexed keywords

ANTIBIOTIC AGENT; BRONCHODILATING AGENT; COLISTIN; CORTICOSTEROID DERIVATIVE; GENTAMICIN; TOBRAMYCIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DATA ANALYSIS; ECONOMIC EVALUATION; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH SERVICE; HOME CARE; HOSPITAL CARE; HOSPITAL COST; HUMAN; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; RESOURCE ALLOCATION; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; UNITED KINGDOM;

ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; CHI-SQUARE DISTRIBUTION; COST-BENEFIT ANALYSIS; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; GREAT BRITAIN; HOME CARE SERVICES; HOSPITALS, SPECIAL; HUMANS; INFUSIONS, INTRAVENOUS; LUNG DISEASES; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 29544432670     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2005.08.003     Document Type: Article

References (20)

1. Press Association UK death rate twice European average Guard Soc Guard 27 2004 (April) London
2. R. Mahadeva K. Webb R.C. Westerbreek et al. Clinical outcome in relation to care in centres specialising in cystic fibrosis: Cross-sectional study BMJ 316 1998 1771-1775
3. G. Packe M. Hodson Changes in spirometry during consecutive admissions for infective exacerbations in adolescent and adult cystic fibrosis Respir Med 86 1992 45-48
4. P. Robinson Cystic fibrosis Thorax 56 2001 237-241
5. M. Pond M. Newport D. Joanes S. Conway Home versus hospital intravenous antibiotic therapy in the treatment of young adults with cystic fibrosis Eur Respir J 7 1995 1640-1644
6. T. Marco O. Asensio M. Bosque J. de Gracia C. Serra Home intravenous antibiotics for cystic fibrosis (Cochrane Review) The Cochrane Library, Issue 1 2001 Update Software Oxford
7. J. Thornton R.A. Elliott M. Tully K. Webb M. Dodd Long-term clinical outcome of home and hospital intravenous antibiotic treatment in adults with cystic fibrosis Thorax 59 2004 242-246
8. R. Knudson M. Lebowitz C. Holberg B. Burrows Changes in the normal maximal expiratory flow-volume curve with growth and aging Am Rev Respir Dis 127 1983 725-734
9. Elliott RA, Thornton J, Tully M, Webb K, Dodd M. Comparing costs of home versus hospital-based treatment of infections in adults in a specialist cystic fibrosis centre. Intl J Technology Assessment in Health Care [in press].
10. J.A. Barber S. Thompson Analysis of cost data in randomized trials: An application of the non-parametric bootstrap Statist Med 19 2000 3219-3236
11. A. Briggs A. Gray The distribution of health care costs and their statistical analysis for economic evaluation J Health Serv Res Policy 3 1998 233-245
12. A. Briggs D. Wonderling C. Mooney Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimation Health Econ 6 1997 327-340
13. E. Fenwick K. Claxton M. Sculpher Representing uncertainty: The role of cost effectiveness acceptability curves Health Econ 10 2001 779-787
14. C. Krauth N. Jalilvand T. Wlete R. Busse Cystic fibrosis: Cost of illness and considerations for the economic evaluation of potential therapies PharmacoEconomics 21 2003 1001-1024
15. D.G. Bosworth D.W. Nielson Effectiveness of home versus hospital care in the routine treatment of cystic fibrosis Pediatr Pulmonol 24 1997 42-47
16. J. Wolter S. Bowler P. Nolan J. McCormack Home intravenous therapy in cystic fibrosis: A prospective randomized trial examining clinical, quality of life and cost aspects Eur Respir J 10 1997 896-900
17. J. Bradley M. Dempster E. Wallace S. Elborn The adaptations of a quality of life questionnaire for routine use in clinical practice: The Chronic Respiratory Disease Questionnaire in cystic fibrosis Qual Life Res 8 1999 65-71
18. W. de Jong A.A. Kaptein C.P. van der Schans G.P.M. Mannes W.M.C. van Aalderen R.G. Grevink et al. Quality of life in patients with cystic fibrosis Pediatr Pulmonol 23 1997 95-100
19. H.E. Elphick A. Tan D. Ashby R.L. Smyth Systematic reviews and lifelong diseases BMJ 325 2002 381-384
20. M.E. Dodd A.K. Webb Understanding non-compliance with treatment in adults with cystic fibrosis J Royal Soc Med 93 Supplement 38 2000 2-38